176 related articles for article (PubMed ID: 25903954)
1. Fenofibrate subcellular distribution as a rationale for the intracranial delivery through biodegradable carrier.
Grabacka M; Waligorski P; Zapata A; Blake DA; Wyczechowska D; Wilk A; Rutkowska M; Vashistha H; Ayyala R; Ponnusamy T; John VT; Culicchia F; Wisniewska-Becker A; Reiss K
J Physiol Pharmacol; 2015 Apr; 66(2):233-47. PubMed ID: 25903954
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of fenofibrate-induced metabolic catastrophe and glioblastoma cell death.
Wilk A; Wyczechowska D; Zapata A; Dean M; Mullinax J; Marrero L; Parsons C; Peruzzi F; Culicchia F; Ochoa A; Grabacka M; Reiss K
Mol Cell Biol; 2015 Jan; 35(1):182-98. PubMed ID: 25332241
[TBL] [Abstract][Full Text] [Related]
3. Development of disulfiram-loaded poly(lactic-co-glycolic acid) wafers for the localised treatment of glioblastoma multiforme: a comparison of manufacturing techniques.
Zembko I; Ahmed I; Farooq A; Dail J; Tawari P; Wang W; Mcconville C
J Pharm Sci; 2015 Mar; 104(3):1076-86. PubMed ID: 25537972
[TBL] [Abstract][Full Text] [Related]
4. Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth.
Benny O; Duvshani-Eshet M; Cargioli T; Bello L; Bikfalvi A; Carroll RS; Machluf M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):768-76. PubMed ID: 15701867
[TBL] [Abstract][Full Text] [Related]
5. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
Kuo YC; Chen YC
Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
[TBL] [Abstract][Full Text] [Related]
6. Endoplasmic reticulum stress involved in high-fat diet and palmitic acid-induced vascular damages and fenofibrate intervention.
Lu Y; Cheng J; Chen L; Li C; Chen G; Gui L; Shen B; Zhang Q
Biochem Biophys Res Commun; 2015 Feb; 458(1):1-7. PubMed ID: 25592967
[TBL] [Abstract][Full Text] [Related]
7. [Kinetics of methyluracil release from bioresorbable polymeric carriers].
Antonov EN; Butnaru DV; Vinarov AZ; Istranova EV; Minaeva SA; Popov VK
Eksp Klin Farmakol; 2015; 78(3):36-9. PubMed ID: 26036010
[TBL] [Abstract][Full Text] [Related]
8. The effect of nanoparticle properties, detection method, delivery route and animal model on poly(lactic-co-glycolic) acid nanoparticles biodistribution in mice and rats.
Simon LC; Sabliov CM
Drug Metab Rev; 2014 May; 46(2):128-41. PubMed ID: 24303927
[TBL] [Abstract][Full Text] [Related]
9. Smart multifunctional core-shell nanospheres with drug and gene co-loaded for enhancing the therapeutic effect in a rat intracranial tumor model.
Wang H; Su W; Wang S; Wang X; Liao Z; Kang C; Han L; Chang J; Wang G; Pu P
Nanoscale; 2012 Oct; 4(20):6501-8. PubMed ID: 22961067
[TBL] [Abstract][Full Text] [Related]
10. Double-effective chitosan scaffold-PLGA nanoparticle system for brain tumour therapy: in vitro study.
Kutlu C; Çakmak AS; Gümüşderelioğlu M
J Microencapsul; 2014; 31(7):700-7. PubMed ID: 24963961
[TBL] [Abstract][Full Text] [Related]
11. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
12. Chemically Modified Variants of Fenofibrate with Antiglioblastoma Potential.
Stalinska J; Zimolag E; Pianovich NA; Zapata A; Lassak A; Rak M; Dean M; Ucar-Bilyeu D; Wyczechowska D; Culicchia F; Marrero L; Del Valle L; Sarkaria J; Peruzzi F; Jursic BS; Reiss K
Transl Oncol; 2019 Jul; 12(7):895-907. PubMed ID: 31078963
[TBL] [Abstract][Full Text] [Related]
13. Surgical delivery of drug releasing poly(lactic-co-glycolic acid)/poly(ethylene glycol) paste with in vivo effects against glioblastoma.
Smith SJ; Rahman CV; Clarke PA; Ritchie AA; Gould TW; Ward JH; Shakesheff KM; Grundy RG; Rahman R
Ann R Coll Surg Engl; 2014 Oct; 96(7):495-501. PubMed ID: 25245726
[TBL] [Abstract][Full Text] [Related]
14. Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells.
Tahara K; Kato Y; Yamamoto H; Kreuter J; Kawashima Y
J Microencapsul; 2011; 28(1):29-36. PubMed ID: 21171814
[TBL] [Abstract][Full Text] [Related]
15. New Photosafety Assessment Strategy Based on the Photochemical and Pharmacokinetic Properties of Both Parent Chemicals and Metabolites.
Kato M; Suzuki G; Ohtake H; Seto Y; Onoue S
Drug Metab Dispos; 2015 Nov; 43(11):1815-22. PubMed ID: 26296710
[TBL] [Abstract][Full Text] [Related]
16. NF-κB/RelA-PKM2 mediates inhibition of glycolysis by fenofibrate in glioblastoma cells.
Han D; Wei W; Chen X; Zhang Y; Wang Y; Zhang J; Wang X; Yu T; Hu Q; Liu N; You Y
Oncotarget; 2015 Sep; 6(28):26119-28. PubMed ID: 26172294
[TBL] [Abstract][Full Text] [Related]
17. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice.
Abou-ElNaga A; Mutawa G; El-Sherbiny IM; Abd-ElGhaffar H; Allam AA; Ajarem J; Mousa SA
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417924
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme.
Ong BY; Ranganath SH; Lee LY; Lu F; Lee HS; Sahinidis NV; Wang CH
Biomaterials; 2009 Jun; 30(18):3189-96. PubMed ID: 19285718
[TBL] [Abstract][Full Text] [Related]
19. Synthetic, implantable polymers for local delivery of IUdR to experimental human malignant glioma.
Williams JA; Yuan X; Dillehay LE; Shastri VR; Brem H; Williams JR
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):631-9. PubMed ID: 9806525
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable polymeric vesicles containing magnetic nanoparticles, quantum dots and anticancer drugs for drug delivery and imaging.
Ye F; Barrefelt A; Asem H; Abedi-Valugerdi M; El-Serafi I; Saghafian M; Abu-Salah K; Alrokayan S; Muhammed M; Hassan M
Biomaterials; 2014 Apr; 35(12):3885-94. PubMed ID: 24495486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
